LeukeranActive Ingredient(s): Chlorambucil
FDA Approved: * March 18, 1957
Pharm Company: * SMITHKLINE BEECHAM
Chlorambucil, sold under the brand name Leukeran among others, is a chemotherapy medication used to treat chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and non-Hodgkin lymphoma. For CLL it is a preferred treatment. It is given by mouth. Common side effects include bone marrow suppression. Other serious side effects include an increased long term risk of further cancer, infertility, and allergic reactions.&... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Leukeran 2 mg Oral TabletNDC: 0173-0635
Leukeran 2 mg Oral TabletNDC: 76388-635
Aspen Global Inc.
Leukeran 2 mg Oral Tablet, Film CoatedNDC: 69784-610
Woodward Pharma Services LLC
Leukeran 2 mg Oral Tablet, Film CoatedNDC: 80725-610
Waylis Therapeutics LLC